David F Burgstahler insider trades: RVL Pharmaceuticals (RVLP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
and 4 more companies
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 8, 2022 | RVLP | ↑ Buy | 8,000,000 | $1.55 | $12.4M | By Avista Capital investment fund | Aug 9, 2022 (1d) |
| Nov 24, 2020 | ORGO | ↑ Buy | 2,839 | $4.99 | $14K | See Notes | Nov 24, 2020 (0d) |
| Nov 19, 2020 | ORGO | ↑ Buy | 4,404,162 | $3.29 | $14.5M | See Notes | Nov 19, 2020 (0d) |
| Mar 16, 2020 | ORGO | ↑ Buy | 542,349 | $3.98 | $2.2M | See Notes | Mar 16, 2020 (0d) |
| Jan 13, 2020 | OSMT | ↑ Buy | 1,250,000 | $5.00 | $6.3M | By Avista Capital investment fund | Jan 15, 2020 (2d) |
| Nov 26, 2019 | ORGO | ↑ Buy | 6,000,000 | $5.00 | $30.0M | See Notes | Nov 27, 2019 (1d) |
| Sep 12, 2019 | ORGO | ↑ Buy | 860,900 | $5.99 | $5.2M | See Notes | Sep 13, 2019 (1d) |
| Sep 10, 2019 | ORGO | ↑ Buy | 537,000 | $5.18 | $2.8M | See Notes | Sep 10, 2019 (0d) |
| Sep 5, 2019 | ORGO | ↑ Buy | 577,600 | $4.84 | $2.8M | See Notes | Sep 5, 2019 (0d) |
| Sep 7, 2017 | LNTH | ↓ Sell | 102,958 | $16.56 | $1.7M | Indirect | Sep 11, 2017 (4d) |
| Sep 6, 2017 | LNTH | ↓ Sell | 78,833 | $16.95 | $1.3M | Indirect | Sep 6, 2017 (0d) |
| Aug 31, 2017 | LNTH | ↓ Sell | 230,685 | $17.25 | $4.0M | Indirect | Aug 31, 2017 (0d) |
| Aug 28, 2017 | LNTH | ↓ Sell | 91,166 | $17.01 | $1.6M | Indirect | Aug 28, 2017 (0d) |
| Aug 16, 2017 | LNTH | ↓ Sell | 140,846 | $17.27 | $2.4M | Indirect | Aug 16, 2017 (0d) |
| Jun 20, 2017 | LNTH | ↓ Sell | 3,000,000 | $14.87 | $44.6M | Indirect | Jun 22, 2017 (2d) |
| May 9, 2017 | LNTH | ↓ Sell | 3,000,000 | $13.40 | $40.2M | Indirect | May 11, 2017 (2d) |
| Apr 12, 2017 | ANGO | ↓ Sell | 2,350,000 | $16.00 | $37.6M | Indirect | Apr 14, 2017 (2d) |
| Mar 17, 2017 | LNTH | ↓ Sell | 3,000,000 | $12.20 | $36.6M | Indirect | Mar 21, 2017 (4d) |
| Nov 21, 2016 | LNTH | ↓ Sell | 2,500,000 | $9.00 | $22.5M | Indirect | Nov 23, 2016 (2d) |
| Nov 18, 2016 | ANGO | ↓ Sell | 2,091,294 | $15.68 | $32.8M | Indirect | Nov 22, 2016 (4d) |
| Sep 19, 2016 | INCR | ↑ Buy | 1,000 | $43.19 | $43K | Direct | Sep 20, 2016 (1d) |
| Aug 5, 2016 | ANGO | ↓ Sell | 2,250,000 | $14.62 | $32.9M | Indirect | Aug 5, 2016 (0d) |
| Mar 7, 2008 | WCRX | ↑ Buy | 10,000 | $15.65 | $157K | Direct | Mar 10, 2008 (3d) |
| Mar 12, 2007 | WCRX | ↑ Buy | 10,000 | $14.77 | $148K | Direct | Mar 13, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David F Burgstahler's insider trades
David F Burgstahler is a director at RVL Pharmaceuticals (RVLP). Since Mar 12, 2007, David has reported 12 open-market purchases worth $76.4M and 12 sales worth $258.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), other transactions (13 filings), shares returned to the company (4 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RVLP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.